Ian Mortimer - PRESIDENT & CEO, Director at Xenon Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
PRESIDENT & CEO, Director
Stock Symbol
XENE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ian Mortimer since 7/8/2023

Holdings reported by Ian Mortimer for Xenon Pharmaceuticals Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Shares 31,302 $308 K $9.85 May 24, 2023 Direct
Common Shares 14,300 $141 K $9.85 May 24, 2023 By Spouse.
Stock Option (Right to Buy) 250,000 Mar 11, 2024 Direct Common Shares

Transactions reported by Ian Mortimer for Xenon Pharmaceuticals Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership